Treprostinil Injection, Solution
Product Images NDC 43598-649

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Treprostinil (NDC 43598-649). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr.reddy's Laboratories Inc.,, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100mgcarton (100mgcarton)

100mgcarton (100mgcarton)
The text is a drug label for Treprostilin Injection, administered for subcutaneous or intravenous infusion. The package contains a 20 mL multiple-dose vial, with each mL of the drug containing 5mg of treprostinil. It is important to dilute the injection before intravenous infusion. The label includes dosage, administration instructions, and storage conditions. The drug is distributed by Dr. Reddy's Laboratories Inc., Princeton, NJ, and made in India.*
FDA Label Image

200mgcarton (200mgcarton)

200mgcarton (200mgcarton)
Treprostinil Injection is a medication that can be given by subcutaneous or intravenous infusion only. It is available in a 20 mL multiple-dose vial containing 200 mg of Treprostinil per 20 mL (10 mg/mL) of the injection. Each mL of the injection also consists of 6.3 mg sodium citrate dihydrate, 4 mg sodium chloride, 3 mg metacresol, 12 mg sodium hydrotide, and Water for Injection. Prior to intravenous infusion, this injection should be diluted. It must be stored at a controlled room temperature between 20-25°C (68-77°F) and kept out of the reach of children. Dosage and administration should be done according to the package insert provided. This product is distributed by Dr. Reddy's Laboratories Inc., Princeton, NJ 08540, and manufactured in India.*
FDA Label Image

20mgcarton (20mgcarton)

20mgcarton (20mgcarton)
Treprostinil is a medication available in a 20mL multiple-dose vial that is meant for subcutaneous or intravenous infusion only. The medication contains 6.3mg sodium citrate dihydrate, 5.3mg sodium chloride, 3mg metacresol, 0.24mg sodium hydroxide, and Water for Injection in addition to the active ingredient, g treprostinil per mL. Prior to intravenous infusion, it should be diluted. The medication must be kept out of reach of children and dosage should be determined based on the package insert. It must be stored between 20°10 25°C (68° 10 77°F) [See USP Controlled Room Temperature]. The medication is distributed by Dr. Reddy’s Laboratories Inc. and made in India.*
FDA Label Image

50mgcarton (50mgcarton)

FDA Label Image

Diluent (Diluent)

Diluent (Diluent)
This is a sterile diluent solution intended for use with Treprostinil injection. Each vial of the solution contains glycine, sodium chloride, sodium hydroxide, and Water for Injection. Storage temperature should be kept between 20°C to 25°C (68°F to 77°F) and should not be frozen. Dilution information can be found in the package insert for Treprostinil injection. This product is distributed by Dr. Reddy's Laboratories and is made in India.*
FDA Label Image

Diluentcarton (Diluentcarton)

Diluentcarton (Diluentcarton)
This text is a product label for a Sterile Diluent for Treprostinil Injection manufactured in India by Dr. Reddy's Laboratories, Inc. The diluent contains glycine, sodium chloride, and water for injection. It is to be used for dilution of treprostinil injection and must be stored between 20-25°C. The package contains a single 50 mL vial suitable for room temperature storage or freezing.*
FDA Label Image

Figure 1 (Figure1)

FDA Label Image

Chemical Structure (Struture)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.